This is a non-core endpoint: only basic statistics are computed.
Use of etanautine orphenadrine
PDMED_ETANAUTINE_ORPHENADRINE
No definition available.
Endpoint definition
↥
FinnGen phenotype data
392423 individuals
Apply sex-specific rule None
392423
Check conditions None
392423
Check pre-conditions, main-only, mode, registry filters
Medicine purchases: ATC
N04AB
1 out of 7 registries used, show all original rules.
16
Check minimum number of events
Min. number of events
3
16
Include endpoints None
16
Remove individuals based on genotype QC
16
PDMED_ETANAUTINE_ORPHENADRINE
Control definitions
Controls for this endpoint are individuals that are not cases.
Extra metadata
First used in FinnGen datafreeze
DF2
Not enough data for upset plot.
Or the full data table
Similar endpoints
↥List of similar endpoints to
Use of etanautine orphenadrine
based on the number of shared cases.
Broader endpoints:
- Any reimbursement code in KELA
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
- Any ICDMAIN event in hilmo or causes of death
- Any prescribed medicine buy
Narrower endpoints:
None
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 16 | 7 | 9 |
| Unadjusted prevalence (%) | 0.00 | 0.00 | 0.01 |
| Mean age at first event (years) | 51.24 | 53.41 | 49.55 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: PDMED_ETANAUTINE_ORPHENADRINE – Use of etanautine orphenadrine
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Use of etanautine orphenadrine
↥Endpoint not on priority list, no data to show.